| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |